Quantum Biopharma Ltd.
QNTM Nasdaq
SEC CIK 1771885
Follow Quantum Biopharma Ltd.
Weekly email: filings, results
EPS, diluted
-
Operating cash flow
−$8.2M
−19.8% vs prior year
Operating income
−$15.3M
+5.2% vs prior year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | - |
| FY22 | −$23.6M |
| FY21 | −$35.3M |
| FY20 | −$31.8M |
| FY19 | −$39.1M |
| FY18 | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$6.9M |
| FY23 | −$10.8M |
| FY22 | −$28.4M |
| FY21 | −$20.7M |
| FY20 | −$19.1M |
| FY19 | - |
| FY18 | - |